Clinical trial
EUS-guided Combined Therapy of Coiling and 2-octyl-cyanoacrylate Injection With Beta Blocker Therapy Versus Beta Blocker Alone for the Primary Prophylaxis of GOV II and IGV I
NCT04075760 is registered in ClinicalTrials.gov with Instituto Ecuatoriano de Enfermedades Digestivas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EUS-guided Combined Therapy of Coiling and 2-octyl-cyanoacrylate Injection With Beta Blocker Therapy Versus Beta Blocker Alone for the Primary Prophylaxis of GOV II and IGV I
- Lead sponsor
- Instituto Ecuatoriano de Enfermedades Digestivas
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 1, 2019
- Completion date
- October 31, 2020
- Enrollment
- 26 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cirrhosis, gastric varix, gastrointestinal bleeding